Search

Your search keyword '"Emily A. Blumberg"' showing total 224 results

Search Constraints

Start Over You searched for: Author "Emily A. Blumberg" Remove constraint Author: "Emily A. Blumberg"
224 results on '"Emily A. Blumberg"'

Search Results

1. Real-world data to improve organ and tissue donation policies: lessons learned from the tissue and organ donor epidemiology study

2. The SHELTER Trial of Transplanting Hepatitis C Virus–Infected Lungs Into Uninfected Recipients

3. One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial

4. The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir

5. A phase I trial of cyclosporine for hospitalized patients with COVID-19

8. Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation

9. One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial

10. Characteristics and Outcomes of Candidemia in Patients with Durable Left Ventricular Assist Device Support

11. Clinical Outcomes and Risk Factors for Carbapenem-resistant Enterobacterales Bloodstream Infection in Solid Organ Transplant Recipients

12. National Landscape of Human Immunodeficiency Virus–Positive Deceased Organ Donors in the United States

13. New Perspectives on Antimicrobial Agents: Maribavir

14. Impact of deceased organ donor injection drug use on donor culture positivity and recipient outcomes

15. Retrospective-prospective study of safety and efficacy of sofosbuvir-based direct-acting antivirals in HIV/HCV-coinfected participants with decompensated liver disease pre– or post–liver transplant

16. C4 article: Implications of COVID-19 in transplantation

17. Kidney transplantation and donation in the transgender population: A single-institution case series

18. Impact of deceased donor multidrug-resistant bacterial organisms on organ utilization

19. Risk Factors for Extended-Spectrum β-lactamase–Producing Enterobacterales Bloodstream Infection Among Solid-Organ Transplant Recipients

20. Delayed mortality among solid organ transplant recipients hospitalized for COVID-19

21. What is the optimal antimicrobial prophylaxis to prevent postoperative infectious complications after liver transplantation? A systematic review of the literature and expert panel recommendations

23. American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease

24. A pragmatic outreach pilot to understand and overcome barriers to COVID-19 vaccination in abdominal organ transplant

25. COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study

26. Antibodies, boosters, and optimizing SARS-CoV-2 vaccines for transplantation: A call for more research

27. Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results

28. New treatments for cytomegalovirus in transplant patients

29. National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys

30. Risk factors for multidrug-resistant organisms among deceased organ donors

31. Early emergence of anti-HCV antibody implicates donor origin in recipients of an HCV-infected organ

32. Active Tuberculosis After Solid Organ Transplantation in Individuals With Negative Pretransplant QuantiFERON-TB Gold Testing: A Case Series

33. Phase 1 Trial of Cyclosporine for Hospitalized Patients with COVID-19

34. Granulomatous Dermatitis Associated With Rubella Virus Infection in an Adult With Immunodeficiency

35. Coronavirus Disease 2019 in Heart Transplant Recipients: Risk Factors, Immunosuppression, and Outcomes

36. Should Health Care Institutions Mandate SARS-CoV-2 Vaccination for Staff?

37. The future of SARS‐CoV‐2 vaccines in transplant recipients: To be determined

38. Clinical prediction tool for extended-spectrum beta-lactamase-producing Enterobacterales as the etiology of a bloodstream infection in solid organ transplant recipients

39. SARS-CoV-2 Vaccination and Solid Organ Transplant Patients: Data Needed to Inform Safety and Efficacy

40. Range and Consistency of Infection Outcomes Reported in Trials Conducted in Kidney Transplant Recipients: A Systematic Review

41. Antibiotic Utilization in Deceased Organ Donors

42. Impact of pre-transplant carbapenem-resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes

43. Healthcare resource use among solid organ transplant recipients hospitalized with COVID‐19

44. The limits of refusal: An ethical review of solid organ transplantation and vaccine hesitancy

45. The Struggling Infectious Diseases Fellow: Remediation Challenges and Opportunities

46. Ten years of donor-derived disease: A report of the disease transmission advisory committee

47. Twelve-Month Outcomes After Transplant of Hepatitis C–Infected Kidneys Into Uninfected Recipients

48. Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation

49. Bacteremia caused by the photosynthetic environmental bacterium Rhodopseudomonas

50. Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis

Catalog

Books, media, physical & digital resources